RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation
The GLORIA-AF registry
Dubner, S. J., Huisman, M. V., Diener, H. C., Halperin, J. L., Rothman, K. J., Ma, C. S., Bergler-Klein, J., Zint, K., Franca, L. R., Lu, S., Teutsch, C., Paquette, M., Lip, G. Y. H., & GLORIA-AF Investigators (2018). Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: The GLORIA-AF registry. European Heart Journal, 39, 606-607.
